Citation: Hd. Polaschegg et al., Characterization of flow-dynamic pattern in a new sorbent cartridge for combined hemoperfusion-hemodialysis, CONTR NEPHR, 133, 2001, pp. 154-165
Authors:
Ronco, C
Brendolan, A
Winchester, JF
Golds, E
Clemmer, J
Polaschegg, HD
Muller, TE
Davankov, V
Tsyurupa, M
Pavlova, L
Pavlov, M
La Greca, G
Levin, NW
Citation: C. Ronco et al., First clinical experience with an adjunctive hemoperfusion device designedspecifically to remove beta(2)-microglobulin in hemodialysis, CONTR NEPHR, 133, 2001, pp. 166-173
Authors:
Winchester, JF
Ronco, C
Brady, JA
Brendolan, A
Davankov, V
Tsyurupa, M
Pavlova, L
Pavlov, M
Clemmer, J
Polaschegg, HD
Muller, TE
La Greca, G
Levin, NW
Citation: Jf. Winchester et al., Rationale for combined hemoperfusion/hemodialysis in uremia, CONTR NEPHR, 133, 2001, pp. 174-179
Citation: K. Sodemann et al., Two years' experience with Dialock (R) and CLS (TM) (A new antimicrobial lock solution), BLOOD PURIF, 19(2), 2001, pp. 251-254
Authors:
Ronco, C
Brendolan, A
Winchester, JF
Golds, E
Clemmer, J
Polaschegg, HD
Muller, TE
La Greca, G
Levin, NW
Citation: C. Ronco et al., First clinical experience with an adjunctive hemoperfusion device designedspecifically to remove beta(2)-microglobulin in hemodialysis, BLOOD PURIF, 19(2), 2001, pp. 260-263
Authors:
Canaud, B
My, H
Morena, M
Lamy-Lacavalerie, B
Leray-Moragues, H
Bosc, JY
Flavier, JL
Chomel, PY
Polaschegg, HD
Prosl, FR
Mcgerman, J
Citation: B. Canaud et al., Dialock: a new vascular access device for extracorporeal renal replacementtherapy. Preliminary clinical results, NEPH DIAL T, 14(3), 1999, pp. 692-698